SCHEMBL21566367

SCHEMBL21566367

c1ccc(-c2cccc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccc7c8ccccc8c8ccccc8c7c6)c5c43)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
FAAH O00519 1/20 0.38
HSP90AA1 P07900 1/20 0.38
PKM P14618 1/20 0.38
MGLL Q99685 1/20 0.38
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
KMT2A Q03164 3/20 0.36
IL1R1 P14778 1/20 0.36
MEN1 O00255 2/20 0.35
MAPT P10636 1/20 0.35
GAA P10253 1/20 0.35
PDE10A Q9Y233 1/20 0.34
WNK1 Q9H4A3 1/20 0.34
OPRD1 P41143 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27044546 0.94 L3MBTL1 (0.47) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL27044556 0.94 L3MBTL1 (0.47) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL27044558 0.94 ATM (0.46) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL16176124 0.94 ATM (0.52) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL21588644 0.93 ATM (0.42) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL12377810 0.92 L3MBTL1 (0.52) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL19769438 0.92 L3MBTL1 (0.56) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL16901463 0.92 L3MBTL1 (0.52) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL24356727 0.92 ATM (0.50) ATML3MBTL1KDM4EALDH1A1HTT
SCHEMBL19769452 0.92 ATM (0.55) ATML3MBTL1KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-09 US disclosed
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-09 US disclosed
US-20240032323-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-01-25 US disclosed
US-20240032323-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-01-25 US disclosed
US-20190348612-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device OR10J3, OCIAD2, OCIAD1 ATM 4252/4885L3MBTL1 4820/4885KDM4E 4422/4885
US-20190348612-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OCIAD2, OR10J3, OCIAD1 ATM 4007/4885L3MBTL1 4726/4885KDM4E 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.